Citadel Advisors
CLLS

Citadel Advisors’s Cellectis CLLS Stock Holding History

Citadel Advisors’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,100
Closed -$5.58K – 14582
2024
Q4 		$5.58K Sell
3,100
-2,800
-47% -$5.22K ﹤0.01% 13853
2024
Q3 		$12.6K Buy
5,900
+3,100
+111% +$6.73K ﹤0.01% 13097
2024
Q2 		$5.24K Buy
+2,800
New +$7.34K ﹤0.01% 13421
2024
Q1 		– Sell
-500
Closed -$1.54K – 14637
2023
Q4 		$1.54K Sell
500
-2,500
-83% -$5.93K ﹤0.01% 13808
2023
Q3 		$4.74K Sell
3,000
-2,300
-43% -$4.49K ﹤0.01% 13456
2023
Q2 		$10.4K Buy
+5,300
New +$10.2K ﹤0.01% 13203
2023
Q1 		– Sell
-700
Closed -$1.47K – 14798
2022
Q4 		$1.47K Buy
+700
New +$1.59K ﹤0.01% 14468
2022
Q2 		– Sell
-14,600
Closed -$66K – 12981
2022
Q1 		$66K Sell
14,600
-6,500
-31% -$35.8K ﹤0.01% 12613
2021
Q4 		$171K Buy
21,100
+4,700
+29% +$46.2K ﹤0.01% 12088
2021
Q3 		$207K Buy
16,400
+2,600
+19% +$36K ﹤0.01% 11915
2021
Q2 		$213K Buy
+13,800
New +$232K ﹤0.01% 12019
2021
Q1 		– Sell
-8,500
Closed -$230K – 13206
2020
Q4 		$230K Buy
+8,500
New +$191K ﹤0.01% 9528
2020
Q3 		– Sell
-14,900
Closed -$265K – 10129
2020
Q2 		$265K Buy
14,900
+4,200
+39% +$63.9K ﹤0.01% 8106
2020
Q1 		$98K Buy
+10,700
New +$160K ﹤0.01% 8645
2019
Q3 		– Sell
-18,700
Closed -$292K – 9208
2019
Q2 		$292K Sell
18,700
-6,600
-26% -$118K ﹤0.01% 7624
2019
Q1 		$464K Buy
25,300
+10,100
+66% +$179K ﹤0.01% 6914
2018
Q4 		$253K Buy
15,200
+1,500
+11% +$34.8K ﹤0.01% 7525
2018
Q3 		$387K Buy
+13,700
New +$394K ﹤0.01% 7135
2018
Q1 		– Sell
-10,200
Closed -$297K – 8311
2017
Q4 		$297K Sell
10,200
-1,200
-11% -$32.7K ﹤0.01% 6479
2017
Q3 		$324K Sell
11,400
-7,400
-39% -$191K ﹤0.01% 5948
2017
Q2 		$485K Buy
18,800
+5,300
+39% +$127K ﹤0.01% 5153
2017
Q1 		$324K Buy
+13,500
New +$284K ﹤0.01% 5778

Other funds holding CLLS

BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citadel Advisors's CLLS Position: Q1 2026 in Review

Citadel Advisors reduced its Cellectis (CLLS) stake by 54% in Q1 2026, selling an estimated $196K and leaving 44,315 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #11740.

Citadel Advisors first reported a position in CLLS in Q1 2015 and has held it in 40 quarters since. The position peaked at $8.53M in Q4 2019. 32 funds tracked by Wall St. Rank hold CLLS as of Q1 2026.

  • Citadel Advisors held 44,315 shares of Cellectis worth $140K as of Q1 2026.
  • Citadel Advisors sold 51,112 Cellectis shares in Q1 2026, an estimated $196K.
  • Cellectis made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11740 holding.
  • Citadel Advisors first reported a position in Cellectis in Q1 2015 and has held it in 40 quarters since.
  • Citadel Advisors's Cellectis position peaked at $8.53M in Q4 2019.
  • 32 funds tracked by Wall St. Rank held Cellectis as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.